Aim: Molecular markers of tumor aggressiveness can improve risk assessment for men with PCa. A large, racially diverse cohort of men (21% African-American -AA) with PCa in the Center for Prostate Disease Research multi-center national database was used to determine the association of the Oncotype DX® Genomic Prostate Score (GPS) with recurrence following radical prostatectomy (RP) for localized PCa.
Vichien Tan合作论文数3
Helen Bailey合作论文数3Joseph Michael Anderson合作论文数3
Frederick Baehner合作论文数Division of Cytopathology, University of California San Francisco;Departments of Pathology and Laboratory Medicine, University of California San Francisco2
Phillip G. Febbo合作论文数Duke Institute for Genome Sciences and Policy, Duke University2
Steven Shak合作论文数Genomic Health2M. Bonham合作论文数1Dejan Knezevic合作论文数1H. Jeffrey Lawrence合作论文数1Ning Zhang合作论文数1D. McLeod合作论文数1R. Lu合作论文数1Yoshizawa Carl N合作论文数1Jun Shan合作论文数1Sing Amy P合作论文数1Butler Steven M合作论文数1
Chantelle Millward合作论文数1Isabell A. Sesterhenn合作论文数1Ali Amina合作论文数1
Shiv Srivastava合作论文数Rockville1Jeffrey G. Lawrence合作论文数1
Tara Maddala合作论文数Genomic Health Inc.1Inger L Rosner合作论文数1Charles P. Quesenberry合作论文数1
Stephen K. Van Den Eeden合作论文数1Robert L Baehner合作论文数1
Timothy Brand合作论文数Department of Urology, Baptist Health Care Center1Jennifer Cullen合作论文数1
